Λίστα αντικειμένων
Combined use of global and targeted analyses allows the cytogenetic classification of
88% of adult patients with Ph-negative BCP-ALL.
• In GRAALL trials, t(4;11)/KMT2A-AFF1 and t(v;14q32)/IGH are the two cytogenetic
anomalies significantly associated with a worse outcome.
Combined use of global and targeted analyses allows the cytogenetic classification of88% of adult patients with Ph-negative BCP-ALL.
In GRAALL trials, t(4;11)/KMT2A-AFF1 and t(v;14q32)/IGH are the two cytogeneticanomalies significantly associated with a worse outcome.
PAper presented by A. Spyridonidis
Participants: all medical staff